NCT02673021 (MARK 1A) is a NA clinical trial of Microwave ablation in Lung Neoplasms, sponsored by Mayo Clinic.

Who is sponsoring NCT02673021?

NCT02673021 is sponsored by Mayo Clinic.

What drugs are being tested in NCT02673021?

Interventions in NCT02673021: Microwave ablation.

What condition does NCT02673021 study?

NCT02673021 studies Lung Neoplasms, Cancer of Lung, Cancer of the Lung, Lung Cancer, Neoplasms, Lung, Neoplasms, Pulmonary, Pulmonary Cancer, Pulmonary Neoplasms, Metastatic Cancer to the Lung.

Is NCT02673021 still recruiting?

NCT02673021 is currently terminated. Last updated 4 October 2023.

Last reviewed 2023-10-04 · How we verify

NCT02673021: MARK 1A

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)

Terminated NA Last updated 4 October 2023

What this trial tests

NA trial testing Microwave ablation in Lung Neoplasms in 9 participants. Terminated before completion.

Timeline

8 June 2016

Primary endpoint
13 March 2020

13 March 2020

Quick facts

Lead sponsor	Mayo Clinic
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	9
Start date	8 June 2016
Primary completion	13 March 2020
Estimated completion	13 March 2020
Sites	2 locations across United States

Drugs / interventions tested

Microwave ablation

Conditions studied

Lung Neoplasms — all drugs for Lung Neoplasms →
Cancer of Lung — all drugs for Cancer of Lung →
Cancer of the Lung — all drugs for Cancer of the Lung →
Lung Cancer — all drugs for Lung Cancer →

Sponsor

Mayo Clinic

Who can join

18 and older, any sex, with Lung Neoplasms or Cancer of Lung. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Does lung ablation improve clinical outcomes for patients deemed to be surgically high-risk?

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A prospective trial of CT-guided percutaneous microwave ablation for lung tumors.
Reisenauer JS, Eiken PW, Callstrom MR, Johnson GB, et al · · 2022 · cited 9× · PMID 35572874 · DOI 10.21037/jtd-21-1636

Verify or expand the search:

Other trials of Microwave ablation

Trials testing the same drug.

NCT07528274 — Microwave Ablation Plus Tislelizumab and Docetaxel in Advanced NSCLC After First-Line Immunotherapy Failure · Phase 2 · recruiting
NCT06969014 — Transbronchial MWA for Pulmonary Tumors · NA · recruiting
NCT06086002 — Clinical Feasibility of Microwave Ablation Using Two Channel Microwave Generator and Two Antennas for Small Hepatocellul · NA · completed
NCT05887154 — Non Surgical Treatment (Microwave Ablation) of Breast Cancer · NA · unknown
NCT05265169 — Ablation With Confirmation of Colorectal Liver Metastases (ACCLAIM) · NA · recruiting

Other recruiting trials for Lung Neoplasms

Currently open trials in the same condition.

NCT07476287 — Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult · Phase 2 · recruiting
NCT07509333 — MDT-Based Umbrella Decision Model for Geriatric Lung Cancer Patients · NA · recruiting
NCT07109154 — DeniLA: Comprehensive Demographics and Clinical Profile of NSCLC Patients: Analyzing Guideline-Concordant Care in First- · recruiting
NCT06974604 — Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM · Phase 2 · recruiting
NCT07165691 — TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for Hispanics · NA · recruiting

Other Mayo Clinic trials

Trials by the same sponsor.

NCT07126548 — A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men · NA · not yet recruiting
NCT07221656 — Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration · not yet recruiting
NCT06891001 — The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, · NA · not yet recruiting
NCT07169799 — Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE) · NA · recruiting
NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02673021 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mayo Clinic
Last refreshed: 4 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02673021.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing